NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CLINUVEL PHARMACEUTICALS LIMITED (CUV)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of CUV: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000CUV3
Address: Level 22, 535 Bourke Street, Melbourne VIC 3000 Australia
Tel:  61 3 9660 4900Fax: 61 3 9660 4999

Date first listed: 13/02/2001
Company Secretary: Mr Darren Keamy
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company focused on dermatology

News & Events

Expand this box to read and print

The suspension of trading in the securities of Clinuvel Pharmaceuticals Limited (the " Company") will be lifted immediately, following the release of an announcement regarding a capital raising. Security Code: CUV

06/05/2013

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) has successfully raised A$6.3 million via a private placement to international institutional and professional investors ("Placement"). The Placement was conducted at price of A$2.136 per share, representing a 4.3% premium to the 20 day volume weighted average price on April 29 and 15.1% to the closing Price on April 30. There was strong participation in the Placement from institutional investors.

06/05/2013

The securities of Clinuvel Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. Security Code: CUV

03/05/2013

we understand that on or about this date the company consolidated its shares 1 for 10

12/11/2010

name changed from Epitan Limited

01/03/2006

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    19/09/2023Philippe Wolgen1,850$16.116$29,814
    26/06/2023Philippe Wolgen1,532$17.720$27,147
    04/11/2022Jeffrey Rosenfeld300$19.440$5,832
    16/06/2022Brenda Shanahan-15,000$14.036$210,536
    07/06/2022Brenda Shanahan-22,392$15.881$355,606

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jeffrey RosenfeldChairman26/11/2019
    Philippe WolgenCEO01/10/2005
    Darren KeamyCFO07/12/2005
    Susan SmithNon Exec Director23/09/2019
    Brenda ShanahanNon Exec Director06/02/2007
    Karen AgersborgNon Exec Director29/01/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Willem BlijdorpNon Exec Director21/01/201521/02/2024
    Andrew LikiermanNon Exec Director04/04/202231/10/2023
    Stanley McLieshNon Exec Chairman12/09/200202/12/2020
    Elia IshagNon Exec Director01/02/201128/11/2017
    Jack WoodNon Exec Director08/07/200828/07/2014
    Helmer AgersborgExecutive Director22/08/200028/09/2012
    Roger AstonNon Exec Director04/04/200503/09/2010
    Terry WintersNon Exec Director22/08/200003/06/2007
    Wayne MillenNon Exec Director09/12/199929/11/2006
    Iain KirkwoodManaging Director30/11/2005
    Alan Cooper02/05/2003
    Malcolm McComasNon Exec Director17/12/199902/07/2002
    Graeme SalthouseChairman02/10/2001

    Date of first appointment, title may have changed.